Interestingly, the identified fusion RNAs included transcripts from well-known oncogenes, previously shown to be important for neuroblastoma biology (i.e., MYCN and LIM domain only 1 LMO1), and they involved chromosomal regions commonly gained or lost in high-risk neuroblastoma [191]. The gene discussed is MYCN; the disease is neuroblastoma.